Immunic, Inc.
DE ˙ DB
16,63 € ↓ -16,55 (-49,87%)
2019-04-18
DEL PRIS
SecurityDE:10V / Immunic, Inc.
InstitutionXTX Topco Ltd
Latest Disclosed Ownership30,824 shares
Latest Disclosed Value $ 34,215
XTX Topco Ltd reports 86.32% decrease in ownership of 10V / Immunic, Inc.

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 30,824 shares of Immunic, Inc. (DE:10V) valued at $34,215 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 225,271 shares of Immunic, Inc.. This represents a change in shares of -86.32% during the quarter. The current value of the position is $512,665 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNIC COM 4525EP101 30,824 -194,447 -86.32 34 -71.67 0.0006
2026-02-17 2025-12-31 13F IMMUNIC COM 4525EP101 225,271 225,271 120 0.0032
2025-05-08 2025-03-31 13F IMMUNIC COM 4525EP101 0 -15,684 -100.00 0 -100.00
2025-02-13 2024-12-31 13F IMMUNIC COM 4525EP101 15,684 -13,273 -45.84 16 -68.09 0.0013
2024-11-14 2024-09-30 13F IMMUNIC COM 4525EP101 28,957 -33,188 -53.40 48 -30.88 0.0035
2024-08-12 2024-06-30 13F IMMUNIC COM 4525EP101 62,145 450 0.73 69 -16.05 0.0059
2024-05-13 2024-03-31 13F IMMUNIC COM 4525EP101 61,695 19,414 45.92 81 28.57 0.0110
2024-02-13 2023-12-31 13F IMMUNIC COM 4525EP101 42,281 17,145 68.21 63 75.00 0.0139
2023-11-13 2023-09-30 13F IMMUNIC COM 4525EP101 25,136 -194,315 -88.55 37 -93.45 0.0063
2023-08-14 2023-06-30 13F IMMUNIC COM 4525EP101 219,451 148,684 210.10 551 423.81 0.0987
2023-05-12 2023-03-31 13F IMMUNIC COM 4525EP101 70,767 70,767 105 0.0221
2022-11-14 2022-09-30 13F IMMUNIC COM 4525EP101 0 -19,972 -100.00 0 -100.00
2022-08-15 2022-06-30 13F IMMUNIC COM 4525EP101 19,972 19,972 69 0.0282
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.